ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 78629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 78629; 2) Community: the network communities that were significantly associated with the response to NSC 78629; 3) Molecule: the relationships between components within communities and NSC 78629; 4) MDR: the compounds that were significantly associated with the NSC 78629.

NSC Compound Enrichment Correlation
NSC 710546 Null 0.0312262198176283 -0.0083491565
NSC 730214 N6-(2-methoxyphenyl)-5-methyl-4-oxo-3-(2-phenoxyethyl)-3,4-d ihydrothieno[2,3-d]pyrimidine-6-carboxamide 0.0312262198176283 0.0088292185
NSC 737132 6-Propyl-2,3-methylenedioxy-8,9-methylenedioxy-11H-indeno-1, 2-c]isoquinolinium Nonaflate 0.0312262198176283 0.62148135
NSC 737225 Null 0.0312262198176283 0.020539077
NSC 756233 GW435821X 0.0312262198176283 0.16856346
NSC 100880 Camptothecin 0.0352383000003056 0.0031004662
NSC 105014 Cladribine 0.0352383000003056 -0.12659702
NSC 114346 Null 0.0352383000003056 0.1382419
NSC 123528 Alanine, 3-[(p-methoxy-.alpha.,.alpha.-diphenylbenzyl)thio]-, hydrate [4:1] 0.0352383000003056 0.2202851
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0352383000003056 0.11282006
Total:49  Current:29    [First] [Prev] [Next] [Last]